Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.


Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

FDA Approves Use of the Prostate Cancer Drug Zytiga Before Hormone Therapy

Men with advanced prostate cancer have another treatment option. In February, the FDA expanded its approval of the drug Zytiga (abiraterone) to include men with metastatic prostate cancer that is still responsive to hormone-blocking treatments.

Read more.

source: Everyday Health